Manufacturing small batches of biopharmaceuticals on demand
Portable biopharmaceutical drug manufacturers could be the future method of producing the drugs on demand for outbreaks of disease...
List view / Grid view
Portable biopharmaceutical drug manufacturers could be the future method of producing the drugs on demand for outbreaks of disease...
The next five years will see game-changing improvements made in upstream, downstream and continuous bioprocessing, predicts one industry specialist...
Direct eye injections treat uveitic macular edema more effectively than treatments placed adjacent to the eye, reveals new Mount Sinai research...
Researchers have developed a tiny, soft drug delivery robot with multiple legs, which is capable of handling and carrying heavy loads...
Moffitt researchers conducted a Phase III trial which found durvalumab to increase the survival of patients with non-small cell lung cancer...
Poor diabetes control leads to an increase in serious infections such as pneumonia, and could mean an increased risk of death...
Two days of free science focused presentations...
Visit Lab Innovations (NEC, 31 October - 1 November) to find out everything you need to know about making your lab more sustainable...
NIAID has released a plan for research in the infectious disease TB in order to strengthen efforts and resolve to attack this disease...
The EMA has revised downwards the number of medicines expected to face Brexit-related supply disruptions from 108, earlier this year, to a current level of 39...
Improved accuracy and fewer patient side effects are among the benefits claimed for the pioneering radiotherapy machine...
PharmaIntegrity makes it quick and easy to identify and trend cleanroom contamination problems before they occur...
Researchers have released data on a clinical trial using specific inhalers and oral capsules to deliver cannabinoids to participants...
The new hub is designed to speed the response to deadly pandemics by improving the development and manufacturing of vaccines – particularly in low- and middle-income countries...
A report has suggested that the biosimilars market growth will increase at a CAGR of 34.2 percent over the course of the period analysed...